Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxic Drug”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01121406
What this trial is testing

BI 6727 (Volasertib) Randomised Trial in Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Boehringer Ingelheim 110
Early research (Phase 1)UnknownNCT02456610
What this trial is testing

Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in China

Who this might be right for
Viral Infection
Affiliated Hospital to Academy of Military Medical Sciences 30
Testing effectiveness (Phase 2)WithdrawnNCT06152523
What this trial is testing

Monalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer

Who this might be right for
MSIdMMR Colorectal Cancer
Assistance Publique - Hôpitaux de Paris
Early research (Phase 1)Looking for participantsNCT04013802
What this trial is testing

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Who this might be right for
Viral Infection
Baylor College of Medicine 47
Testing effectiveness (Phase 2)Ended earlyNCT01205334
What this trial is testing

Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma MultiformeGBMBrain Cancer
Baylor College of Medicine 2
Testing effectiveness (Phase 2)Study completedNCT00079768
What this trial is testing

Alemtuzumab to Treat Sporadic Inclusion Body Myositis

Who this might be right for
Myositis, Inclusion Body
National Institute of Neurological Disorders and Stroke (NINDS) 20
Not applicableStudy completedNCT04694794
What this trial is testing

Diminish Chemotherapy Related Side Effects Through Patient Education

Who this might be right for
Chemotherapeutic ToxicityChemotherapeutic Agent ToxicityChemotherapy Effect
Milton S. Hershey Medical Center 36
Large-scale testing (Phase 3)Ended earlyNCT05305040
What this trial is testing

Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Adenovirus InfectionBK Virus InfectionCytomegalovirus Infections+3 more
AlloVir 451
Testing effectiveness (Phase 2)UnknownNCT06075927
What this trial is testing

Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT

Who this might be right for
CMV InfectionEBV InfectionStem Cell Transplant
Peking University People's Hospital 29
Testing effectiveness (Phase 2)Ended earlyNCT02205333
What this trial is testing

A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies

Who this might be right for
Advanced Solid TumorsAggressive B-cell Lymphomas
MedImmune LLC 48
Early research (Phase 1)Study completedNCT04765449
What this trial is testing

Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection

Who this might be right for
Covid19
Thomas Jefferson University 30
Early research (Phase 1)Study completedNCT02510417
What this trial is testing

Allogeneic Virus-specific T Cell Lines (VSTs)

Who this might be right for
Viral Infections After HSCT
Catherine Bollard 31
Not applicableStudy completedNCT02108522
What this trial is testing

Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant

Who this might be right for
Infection
AlloVir 82
Testing effectiveness (Phase 2)WithdrawnNCT03353428
What this trial is testing

Intervention of Engineered Immune Effector T Cells Against Lung Cancer

Who this might be right for
Lung CancerNSCLC
Shenzhen Geno-Immune Medical Institute
Early research (Phase 1)Study completedNCT02278250
What this trial is testing

First in Human Study of M4344 in Participants With Advanced Solid Tumors

Who this might be right for
Solid TumorAdvanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 97
Testing effectiveness (Phase 2)Looking for participantsNCT05773859
What this trial is testing

NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerOvarian Carcinoma
Radboud University Medical Center 10
Early research (Phase 1)Study completedNCT01422850
What this trial is testing

Safety Study of Repeated Dosing of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy

Who this might be right for
Hormone-refractory Prostate Cancer
CytoVac A/S 21
Early research (Phase 1)Study completedNCT00673868
What this trial is testing

Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants

Who this might be right for
Cytomegalovirus Infections
Milton S. Hershey Medical Center 2
Testing effectiveness (Phase 2)Study completedNCT01570283
What this trial is testing

ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus

Who this might be right for
Viral Infection
AlloVir 21
Early research (Phase 1)Study completedNCT01460901
What this trial is testing

Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Mercy Hospital Kansas City 5
Next Page